News Related to Encephalitis

Related coverage linked through entity extraction aliases.

NanoViricides Files Orphan Drug Designation Application for Measles Treatment NV-387

Feb 15, 2026

NanoViricides has filed an orphan drug designation application with the FDA for NV-387 as a measles treatment, amid rising U.S. cases that reached 2,251 in 2025 with 3 deaths and 727 cases already reported in early 2026.

Encephalitis Global Clinical Trials Review 2025 Report Released

Feb 19, 2026

A comprehensive report on encephalitis clinical trials has been added to ResearchAndMarkets.com's offering, providing data on trial numbers, enrollment trends, and geographic distribution across G7 and E7 countries.